Zonisamide and Otezla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zonisamide (zonisamide) and Otezla (apremilast). Common drug interactions include back pain among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Zonisamide and Otezla. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Zonisamide?

Zonisamide has active ingredients of zonisamide. It is often used in epilepsy. eHealthMe is studying from 11,445 Zonisamide users. Check the latest studies of Zonisamide.

What is Otezla?

Otezla has active ingredients of apremilast. It is often used in psoriatic arthritis. eHealthMe is studying from 146,254 Otezla users. Check the latest studies of Otezla.



On Jul, 28, 2026

19 people who take Zonisamide and Otezla together, and have interactions are studied.

Zonisamide and Otezla drug interactions.

What are the common drug interactions of Zonisamide and Otezla, by gender? *:

female:

  1. Back pain
  2. Discomfort
  3. Psoriasis (immune-mediated disease that affects the skin)
  4. Tenderness (pain or discomfort when an affected area is touched)
  5. Nausea (feeling of having an urge to vomit)
  6. Peripheral swelling
  7. Pulmonary mass
  8. Rash generalised (rash on most of body parts)
  9. Respiratory tract infection
  10. Skin irritation

male:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Blood alkaline phosphatase increased
  4. Diarrhoea
  5. Gamma-glutamyltransferase increased
  6. Hepatic enzyme increased
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)

What are the common drug interactions of Zonisamide and Otezla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Arthralgia (joint pain)
  2. Diarrhoea
  3. Fatigue (feeling of tiredness)
  4. Headache (pain in head)
  5. Psoriasis (immune-mediated disease that affects the skin)

40-49:

  1. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  2. Pain
  3. Peripheral swelling
  4. Pulmonary mass
  5. Respiratory tract infection

50-59:

  1. Alopecia (absence of hair from areas of the body)
  2. Chills (felling of cold)
  3. Diarrhoea
  4. Hyperhidrosis (abnormally increased sweating)
  5. Infection
  6. Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
  7. Nausea (feeling of having an urge to vomit)
  8. Psoriasis (immune-mediated disease that affects the skin)
  9. Sinus congestion (blockage of sinus)

60+:

  1. Diarrhoea
  2. Headache (pain in head)
  3. Vomiting
  4. Back pain
  5. Discomfort
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Tenderness (pain or discomfort when an affected area is touched)
  9. Eructation (release of gas from the digestive tract)
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 15 people, 78.95%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 15.79%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 15.79%
  4. Gastric Ulcer (stomach ulcer): 3 people, 15.79%
  5. Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 3 people, 15.79%
  6. High Blood Pressure: 3 people, 15.79%
  7. Iron Deficiency: 3 people, 15.79%
  8. Pain: 3 people, 15.79%
  9. Joint Pain: 2 people, 10.53%
  10. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Zonisamide and Otezla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zonisamide and Otezla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zonisamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Otezla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zonisamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Otezla and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on zonisamide and apremilast (the active ingredients of Zonisamide and Otezla, respectively), and Zonisamide and Otezla (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: